Dr. Reddy’s Laboratories shares were in the spotlight on Wednesday after the company’s management expressed confidence in achieving strong financial growth in FY26. As of 11:24 AM, the shares were trading 0.67% lower at Rs 1,291.10.
In a recent update, the company’s Chief Financial Officer stated that Dr. Reddy’s is aiming for double-digit sales growth and a robust 25% EBITDA margin for the current financial year.
Dr. Reddy’s Laboratories shares traded in a narrow range today. The stock opened at ₹1,298.10, slightly lower than its previous close of ₹1,299.80. During the session, it touched an intraday low of ₹1,277.70 and a high of ₹1,298.10. Over the past 52 weeks, the stock has seen a low of ₹1,020.00 and a high of ₹1,421.49.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
